AQP9 and metabolic dysfunction-associated steatotic liver disease: AQP9 down-regulation and reduction in hepatic glycerol permeability in insulin-resistant conditions were interpreted in a way whereby the hepatocytes counteract further fat accumulation within its parenchyma and diminish hepatic gluconeogenesis during NAFLD.